Long-Term Liabilities: The sum of all non-current liabilities.
Hikma Pharmaceuticals Plc (HKMPF) had Long-Term Liabilities of $834.00M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.26B |
|
$2.33B |
|
$3.87B |
|
$5.13B |
|
$1.98B |
|
$653.00M |
|
|
Long-Term Liabilities |
$834.00M |
$2.81B |
|
$2.32B |
|
$1.17B |
|
$2.32B |
|
-- |
|
| Cash Flow Statement Financials | |
$564.00M |
|
$-381.00M |
|
$-188.00M |
|
$205.00M |
|
$188.00M |
|
$-17.00M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|